The gradated administration of NSCLC cells to chemodrugs unveiled Aldo-keto reductase family 1 member B 10 (AKR1B10) as the most potent regulator in the resilience development that was functionally characterized in the present study. This evidence concerns the gene AKR1B10 and non-small cell lung carcinoma.